Gates Foundation, Mastercard, Wellcome launch coronavirus treatment accelerator as outbreak deepens
A month after announcing it was prepared to spend $100 million on R&D efforts against the novel coronavirus — and with the outbreak showing no signs of waning — the Bill and Melinda Gates Foundation revealed where much of that money would be spent.
The foundation, Wellcome and Mastercard launched the Covid-19 Therapeutics Accelerator today. With $50 million each from Gates and Wellcome and $25 million from Mastercard, the accelerator will support pharmaceutical companies, biotechs and academic researchers hunting for antivirals that can treat the novel coronavirus that has now claimed over 4,000 lives worldwide.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.